sotrovimab
Distribution of sotrovimab has been discontinued nationally due to the decreased efficacy of it with the now dominant SARS-CoV-2 Omicron BA.2 sub-variant.
Reviewed: June 2021 (Sotrovimab)
Updated: Feb. 2022 (Sotrovimab)
Updated: April 2022 (Sotrovimab)
Distribution of sotrovimab has been discontinued nationally due to the decreased efficacy of it with the now dominant SARS-CoV-2 Omicron BA.2 sub-variant.
Reviewed: June 2021 (Sotrovimab)
Updated: Feb. 2022 (Sotrovimab)
Updated: April 2022 (Sotrovimab)